Skip to search formSkip to main contentSkip to account menu

Carteolol

Known as: 2(1H)-Quinolinone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, Carteolol [Chemical/Ingredient], Carteololum 
A synthetic quinolinone derivative and nonselective beta-adrenoceptor blocking agent with anti-glaucoma activity. Upon topical administration to the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
AbstractCarteolol, a nonselective beta-adrenergic antagonist with intrinsic sympathomimetic activity, was compared in 1% and 2… 
1991
1991
SummaryMany antihypertensive drugs are extensively metabolised in humans. Since some metabolites are active and may therefore… 
1987
1987
Interactions of derivatives of befunolol (BFE-37, BFE-55, and BFE-61), carteolol, and pindolol with beta-adrenoceptors were… 
1986
1986
Seventy-two patients entered the treatment phase of an open, long-term, dose-ranging trial of carteolol in stable, exercise… 
1986
1986
The type of adrenoceptor involved in the contractile response to catecholamines in smooth muscle strips isolated from rainbow… 
1986
1986
The long-term safety and antihypertensive efficacy of carteolol were evaluated in an open-label, multicenter trial of 245… 
1986
1986
Effects of dl- and d-carteolol alone on the release of tritium evoked by transmural field stimulation at 1 Hz were investigated… 
1983
1983
: The compound known as 5-(3-tert-butylamino-2-hydroxy-propoxy)-3,4-dihydro-2 (1H)-quinolinone hydrochloride (carteolol… 
1979
1979
Direct effects of 5-(3-tert.-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol) on chronotropic and… 
1978
1978
In open-chest dogs the heart rate was controlled at 150 beats/min and drugs were given intravenously. Propranolol (30 microgram…